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Abstract
Background: Syndromic management is an inexpensive and effective method for the treatment of symptomatic sexually
transmitted infections (STIs), but its effectiveness as a method of STI control in at-risk populations is questionable. We
sought to determine the potential utility of syndromic management as a public health strategy to control STI transmission
in high-risk populations in urban Peru.
Methodology: We surveyed 3,285 at-risk men and women from three Peruvian cities from 2003–05. Participants were asked
about the presence of genital ulcers, discharge, or dysuria in the preceding six months. Participants reporting symptoms
were asked about subsequent health-seeking and partner notification behavior. Urine and vaginal swab samples were
tested for Neisseria gonorrhoeae and Chlamydia trachomatis by nucleic acid testing. Serum was tested for syphilis and
Herpes Simplex Virus-Type 2 antibodies.
Findings: Recent urogenital discharge or dysuria was reported by 42.1% of participants with gonorrhea or chlamydia versus
28.3% of participants without infection. Genital ulceration was reported by 6.2% of participants with, and 7.4% of
participants without, recent syphilis. Many participants reporting symptoms continued sexual activity while symptomatic,
and approximately half of all symptomatic participants sought treatment. The positive and negative predictive values of
urogenital discharge or genital ulcer disease in detecting STIs that are common in the study population were 14.4% and
81.5% for chlamydia in women and 8.3% and 89.5% for syphilis among gay-identified men.
Conclusions: In our study, STIs among high-risk men and women in urban Peru were frequently asymptomatic and
symptomatic participants often remained sexually active without seeking treatment. Additional research is needed to assess
the costs and benefits of targeted, laboratory-based STI screening as part of a comprehensive STI control program in
developing countries.
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Introduction
Syndromic management is a simple and effective method for the
treatment of symptomatic sexually transmitted infections (STIs) in
resource-limited settings [1–6]. Several studies have demonstrated
improvements in clinical STI management following training for
healthcare professionals using World Health Organization guide-
lines for syndromic treatment of urethritis and genital ulceration
[6–8]. However, in many developing countries, limited healthcare
resources also lead to a reliance on syndromic management as the
primary method for the detection and treatment of STIs in the
population. Despite its utility in the treatment of symptomatic
infection, little data is available concerning the effectiveness of
syndromic management as a strategy to control STI transmission
in resource-limited environments [9–12].
In Peru, as in many developing countries, standard clinical
approaches to urethritis, genital ulcer disease (GUD), cervicitis,
and pelvic inflammatory disease are based on syndromic
management principles. According to practice guidelines issued
by the Peruvian Ministry of Health, patients presenting with signs
or symptoms of dysuria, urethral discharge, vaginal discharge, or
cervicitis should be treated presumptively for both gonorrhea and
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7201chlamydia [13]. Patients who are found to have GUD on physical
examination or who report a recent history of a spontaneously
resolving genital ulcer should be screened with a Rapid Plasma
Reagin (RPR) assay and, if reactive, treated for both syphilis and
chancroid. (For ulcerative lesions with a vesicular appearance, the
guidelines also recommend empiric acyclovir treatment.) While
men who have sex with men (MSM), sex workers and pregnant
women are recommended to undergo routine serologic testing for
HIV and syphilis, screening procedures for other STIs, including
gonorrhea and chlamydia, and in other at-risk populations are
based primarily on a syndromic approach.
We sought to assess the utility of syndromic management as a public
health strategy to control STI transmission in high-risk populations
in urban Peru. We analyzed previously collected data from a sample
of at-risk men and women in three coastal Peruvian cities to quantify
the prevalence of symptomatic and asymptomatic STIs, the parti-
cipant’s subsequent response to symptoms, and the public health
implications of a primarily syndromic approach to STI control.
Methods
Study Design
As part of an international HIV/STI prevention trial, we
conducted an epidemiological survey of low-income populations
from three coastal cities in Peru between 2003 and 2005. Baseline
surveys were completed in Lima in 2003 and in the cities of
Trujillo and Chiclayo in 2005. A total of 20 low-income urban
communities (barrios) in the three cities were identified for
participant recruitment. Three subpopulations at risk for HIV
and STI transmission were identified during ethnographic analysis
of the barrios: gay-identified men who have sex only with men,
heterosexual-identified men who engage in sex with multiple
partners that may include other men, and sexually active
heterosexual-identified women. Detailed information concerning
the identification and recruitment of the three high-risk subpop-
ulations has been published previously [14,15]. Briefly, men and
women from these subpopulations were eligible for enrollment if
they were 18–40 years old, planned to remain in the area for the
entire length of the study (two years), and regularly visited areas of
high-frequency social interaction in the barrio (e.g., soccer fields,
hair salons, and street corners). Approximately 150 eligible
individuals were recruited from each barrio. All respondents who
agreed to participate provided written informed consent. The
study protocol was approved by the Committee of Human
Subjects Research of the University of California at Los Angeles,
the Universidad Peruana Cayetano Heredia, and the U.S. Naval
Medical Research Center in Bethesda, MD in compliance with all
federal regulations regarding the protection of human subjects.
Data Collection
Participants were interviewed in a temporary project office
located in their barrio with a Computer Assisted Personal
Interviewing system. Trained staff read participants questions in
Spanish and entered the responses directly into a secure computer
database. Participants were assured of the confidentiality of all of
their responses. All participants were asked whether they had
experienced dysuria or ‘‘pain when you urinated’’ (‘‘te dolio ´a l
orinar’’), penile or vaginal ‘‘discharge or secretions,’’ (‘‘descarga uretral
o secreciones’’), or a ‘‘genital ulcer’’ (‘‘u ´lcera genital’’) on their penis or
vagina within the previous six months (there were no questions
concerning anorectal symptoms). An affirmative response to any of
these questions prompted a series of follow-up questions about
actions taken following the onset of symptoms including whether
they did anything to prevent infecting their sex partner(s), whether
they did anything to cure themselves of the symptoms and, if so,
what specific actions were taken. All participants were asked the
same questions, regardless of gender or reported sexual behavior.
Study interviewers provided pre-test counseling and phleboto-
my staff collected blood samples from all participants. Women
were asked to self-collect a vaginal swab specimen. All men, and
any women who declined to collect a vaginal swab, were asked to
provide a urine sample. Approximately one month after the initial
evaluation, participants returned for post-test counseling and
provision of results. Participants with a curable STI were provided
with appropriate antibiotic therapy. Participants with symptomatic
Herpes Simplex Virus Type 2 infection were treated with
acyclovir. Participants diagnosed with HIV infection were referred
to specialized Ministry of Health treatment centers for ongoing
care. All participants diagnosed with an STI were advised of the
importance of partner notification and were offered free partner
testing and treatment at the study site.
Laboratory Methods
Biological samples were processed at the U.S. Naval Medical
Research Center Detachment in Lima, Peru. Urine and vaginal
swab specimens were analyzed for the presence of Neisseria
gonorrhoeae (GC) and Chlamydia trachomatis (CT) with nucleic acid
amplification testing (Amplicor, Roche Diagnostics; Alameda,
CA). Blood was screened for syphilis infection by RPR assay
(RPRnosticon, Biome ´rieux; Marcy l’E ´toile, France). RPR-positive
specimens were confirmed by Treponema Pallidum Particle
Agglutination (TPPA) assay (Serodia, Fujirebio; Tokyo, Japan)
and the RPR titer quantified. Only TPPA-positive specimens with
RPR titers $1:8 (suggestive of recent infection) were included in
our analysis. Serum antibodies to Herpes Simplex Virus- Type 2
(HSV-2) were detected by ELISA assay (HerpeSelect, Focus
Technologies; Cypress, CA), using a cut-off index value of .3.49
to define seropositive specimens.
Data Analysis
We analyzed results using chi-square tests and Fisher’s exact
tests when appropriate. All p-values are two-sided and considered
statistically significant if p,0.05. Stata 9.0 software was used for all
analyses (Stata Corporation, College Station, TX).
Results
Sociodemographic Factors
A total of 3,301 participants were enrolled, of whom 3,285
provided biological samples (Table 1). Among the three sub-
populations, 2,424 participants (73.8%) were heterosexual-identi-
fied men, 541 (16.4%) were homosexual-identified men, and 320
(9.7%) were heterosexual women. The age range of participantswas
18–41, with a median age of 23 years (interquartile range: 20–27).
Prevalence of Genitourinary Symptoms
Among all participants, regardless of STI status, 27.0% reported
symptoms of genital discharge and/or dysuria in the previous six
months. Genital discharge or dysuria was reported by 42.1% of all
participants with gonorrhea or chlamydia, and by 48.1% of
women with gonorrhea or chlamydia. An ulcerative genital lesion
during the previous six months was reported by 7.2% of all
participants, by 6.2% of all participants with an RPR titer $1:8,
and by 3.5% of gay-identified men with an RPR titer $1:8.
Participant Response to Symptoms
The actions taken by participants in response to reported
symptoms are described in Tables 2 and 3. Few differences in
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Trujillo, and Chiclayo, Peru; 2003–05.
Heterosexual
Men n=2424
Homosexual
Men n=541
Heterosexual
Women n=320
Total
n=3285
Demographics
Age (years)
Median (IQR)
a 22 (20–26) 26 (23–32) 25 (21–31) 23 (20–28)
Relationship status
Single 1689 69.7% 511 94.5% 116 36.3% 2316 70.5%
Primary partner 612 25.3% 27 5.0% 162 50.6% 801 24.4%
Formerly married 122 5.0% 3 0.6% 42 13.1% 167 5.1%
Graduated high school 1163 48.0% 358 66.2% 130 40.6% 1651 50.3%
Had a child/children 738 30.5% 18 3.3% 239 74.7% 995 30.3%
Regularly earns money 2073 85.5% 443 81.9% 178 55.6% 2694 82.0%
Prevalence of STI Symptoms
Dysuria 655 27.1% 96 17.8% 135 42.2% 886 27.0%
Urethral discharge 77 3.2% 9 1.7% 104 32.6% 190 5.8%
Genital ulcer 196 8.1% 24 4.4% 20 6.3% 240 7.3%
Prevalence of Laboratory-confirmed STIs
Herpes Simplex Virus-2 315 13.0% 373 69.0% 130 40.6% 818 24.9%
Syphilis (Any RPR) 56 2.3% 120 22.2% 12 3.8% 188 5.7%
Syphilis (RPR $1:8) 33 1.4% 57 10.5% 7 2.2% 97 3.0%
Gonorrhea
b 11 0.5% 2 0.4% 9 2.8% 22 0.7%
Chlamydia
b 127 5.2% 6 1.1% 45 14.1% 178 5.4%
a Interquartile range
b Genital only
doi:10.1371/journal.pone.0007201.t001
Table 2. Response to STI Symptoms (All Participants); Lima, Trujillo and Chiclayo, Peru; 2003–05.
Heterosexual-
identified Men
Homosexual-
identified Men Women All
Discharge cases (n) 77 9 105 191
Told partner (%) 22.1 22.2 54.3 39.8
Abstinence (%) 39.0 77.8 51.4 47.6
‘‘Did something’’ about symptoms (%) 58.4 77.8 62.9 61.8
Used condom (%) 5.2 11.1 4.8 5.2
Used folk remedy (%) 9.1 11.1 26.7 8.8
Used medicine (%) 53.3 66.7 45.7 49.7
Other (%) 1.3 11.1 2.9 2.6
Ulcer cases (n) 197 24 20 241
Told partner (%) 43.1 33.3 65.0 44.0
Abstinence (%) 42.6 29.2 40.0 41.1
‘‘Did something’’ about symptoms (%) 68.0 62.5 60.0 66.8
Used condom (%) 7.1 8.3 0.0 6.6
Used folk remedy (%) 22.3 20.8 35.0 23.2
Used medicine (%) 48.7 45.8 50.0 48.6
Other (%) 5.6 4.2 0.0 5.0
doi:10.1371/journal.pone.0007201.t002
Syndromic Management in Peru
PLoS ONE | www.plosone.org 3 September 2009 | Volume 4 | Issue 9 | e7201participant behavior were observed when analyzed according to
gender, sexual identity, or type of symptoms. Although the
majority of women reported notifying their sex partner(s) when
they experienced genital discharge or ulceration, the majority of
men, regardless of their sexual identity, did not inform their
partners of any genitourinary symptoms. Among participants who
reported genital discharge, 61.8% (118/191) took some action to
cure their symptoms, and 49.7% (95/191) used medicine to treat
their symptoms. For participants reporting genital ulceration,
66.7% (161/241) took some curative action and 48.6% (117/241)
used medicine. Ultimately, 9.6% of participants with laboratory-
confirmed gonorrhea or chlamydia and 5.2% of participants with
recent syphilis received some form of medical treatment prior to
study enrollment (Figures 1 and 2). Symptomatic participants who
had sought treatment were more likely than those who did not seek
treatment prior to enrollment to be diagnosed with gonorrhea or
chlamydia at the time of evaluation (9.6% vs. 2.5%; p,0.001),
though they were not significantly more likely to be diagnosed with
syphilis (5.2% vs. 3.4%; p=0.348). A substantial minority of
symptomatic participants continued to engage in sexual activity
Figure 1. Pre-enrollment Treatment Outcomes Among Men and Women with Genital Gonorrhea and/or Chlamydia; Lima, Trujillo
and Chiclayo, Peru 2003–05.
doi:10.1371/journal.pone.0007201.g001
Table 3. Response to STI Symptoms (Participants with Ongoing Sexual Activity); Lima, Trujillo and Chiclayo, Peru 2003–05.
Heterosexual-identified Men Homosexual-identified Men Women All
Discharge cases (n) 30 7 54 91
‘‘Did something’’ about symptoms (%) 40.0 85.7 61.1 56.0
Used condom (%) 13.3 14.3 9.3 11.0
Used folk remedy (%) 10.0 14.3 31.5 23.1
Used medicine (%) 30.0 71.4 40.7 39.6
Other (%) 3.3 14.3 3.7 4.4
Ulcer cases (n) 84 7 8 99
‘‘Did something’’ about symptoms (%) 64.3 57.1 50.0 62.6
Used condom (%) 16.7 28.6 0.0 16.2
Used folk remedy (%) 21.4 0.0 25.0 20.2
Used medicine (%) 44.0 28.6 50.0 43.4
Other (%) 7.1 14.3 0.0 20.2
doi:10.1371/journal.pone.0007201.t003
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ulceration [41.1% (99/241)]. Participants who sought treatment
for their symptoms were more likely to abstain from sex than those
who took no protective action while experiencing genital discharge
(58% vs. 44%; p=0.063) or ulceration (64% vs. 49%; p=0.022).
STI Prevalences
The prevalence of gonorrhea or chlamydia, syphilis and HSV-2
infection in the study population is reported in Table 1. Active
syphilis (RPR$1:8) was diagnosed in 10.5% (57/541) of homosex-
ual-identified men, 1.4% (33/2424) of heterosexual-identified men,
and 2.2% (7/320) of women. Urogenital gonorrhea or chlamydia
was identified in 1.5% (8/544) of homosexual men, 5.6% (137/
2434) of heterosexual men and 16.2% (52/320) of women.
Diagnostic Performance of Symptomatic Screening
Criteria
The diagnostic performance of symptom recognition for STI
screening in our study population is reported in Table 4.
Participant-reported genital discharge and/or dysuria in the
preceding six months had a positive predictive value (PPV) of
14.4% and a negative predictive value (NPV) of 81.5% for
gonorrhea or chlamydia in women. Among homosexual-identified
men, the PPV and NPV of self-reported recent genital ulceration
for active syphilis was 8.3% and 89.5%, respectively, and 79.2%
and 29.5% in screening for HSV-2 infection.
Discussion
Based on our analysis of reported genitourinary symptoms,
subsequent treatment-seeking behavior, and laboratory-based STI
screening among high-risk men and women in urban Peru, an STI
control strategy based solely on syndromic management would not
be sufficient to address commonly occurring STIs in this
population. In our analysis, screening criteria such as partici-
pant-reported episodes of dysuria, genital discharge, and genital
ulceration had poor positive and negative predictive values when
compared with laboratory-based testing for gonorrhea, chlamydia
and recent syphilis in sub-populations of men and women with a
high prevalence of infection. The inability of the assessed
symptomatic complexes to account for asymptomatic STIs that
may result in clinical morbidity and continued STI transmission
was compounded by the failure of many subjects who experienced
symptoms to seek medical treatment [16–19].
Multiple studies have demonstrated the value of syndromic
management in the empiric diagnosis and treatment of patients
presenting for care with symptomatic STIs. In a series of studies in
Peruvian pharmacies and other healthcare settings, Garcia et al.
found syndromic management to be an effective and inexpensive
method for the clinical management of symptomatic STIs [3,8,20–
22]. While our data suggests concerns related to unnecessary
antibiotic use resulting from the low diagnostic specificity of
syndromic management, it remains an inexpensive and readily
available method for the diagnosis and treatment of symptomatic
STIs in both developing and developed countries.
For subpopulations with a high burden of asymptomatic
infections, including syphilis in men who have sex with men
(MSM) and chlamydia in heterosexual women, our data suggest
the need for routine screening of these specific, high-prevalence
STIs. In our sample, the majority of diagnosed cases of gonorrhea
or chlamydia and untreated syphilis were asymptomatic, less than
half of participants with symptoms sought any form of medical
treatment, and one-third of symptomatic participants took no
Figure 2. Pre-enrollment Treatment Outcomes Among Men and Women with Recent Syphilis (RPR$1:8); Lima, Trujillo and
Chiclayo, Peru 2003–05.
doi:10.1371/journal.pone.0007201.g002
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heterosexual women and recent syphilis in MSM in our study
population would only have been detected through a program of
routine laboratory screening directed towards the specific STIs
endemic to these sub-populations. As a result, we would argue that
laboratory-based STI screening, guided by individual risk
behavior history and regional epidemiologic data on STI
prevalence, is an essential complement to syndromic management
of symptomatic infections for STI control in developing regions of
Latin America.
Our study has several limitations that could have influenced
our findings. Our data was collected as part of an HIV/STI
prevention trial that was not specifically designed to assess
syndromic management as an STI control strategy. Symptomatic
infections were identified as those where participants reported
symptoms at any time within the previous six months. This
definition may have increased the sensitivity of ‘‘symptomatic’’
criteria for STI detection, but limited their specificity for
diagnosis. Participants were not physically examined to assess
for the presence of clinical signs of infection, and there were no
follow-up questions to elaborate on reported symptoms of
dysuria, urogenital discharge, or genital ulceration. In particular,
the lower prevalence of laboratory-confirmed gonorrhea and
chlamydia among symptomatic participants who did not seek
treatment compared with those who sought attention for their
symptoms suggests the possibility that some of the symptoms
reported by this subgroup would have been found to be minimal
on further questioning. The reasons why participants did or did
not seek treatment were not elicited in our survey and indicate an
important area for future research. We are also uncertain of the
impact of previous antibiotic treatment on the participant’s STI
status at enrollment. Appropriate antibiotic treatment may have
reduced our estimate of the prevalence of laboratory-confirmed
STIs among participants with genitourinary symptoms and, as a
result, the estimated specificity of syndromic diagnosis. However,
we do not have information on the medication used and cannot
determine if the treatment was indicated for the participant’s
symptoms, appropriate for their syndromic diagnosis, or effective
in treating their infection. Finally, we did not assess for rectal or
pharyngeal STIs byclinical historyor laboratory analysis, leaving
an important gap in the knowledge of STI epidemiology in Peru.
Despite these limitations, the diagnostic approach and questions
used in our study are consistent with typical screening guidelines
for the syndromic evaluation of patients at risk for STI
acquisition and reflect the impact of a syndromic approach to
diagnosis.
As illustrated in our findings, while syndromic management
may be an effective method for clinical management of
symptomatic STIs, it fails to address the large number of infections
that are asymptomatic or otherwise unrecognized by patients, and
is inadequate as a primary method for STI control in resource-
limited settings. In addition to standard public health measures
such as behavioral risk reduction counseling, partner notification
and treatment, and condom distribution, laboratory-based screen-
ing targeting specific, high-prevalence STIs in at-risk sub-
populations provide an important adjunct to syndromic manage-
ment for STI control efforts in Peru and other developing
countries. Further research is needed to determine the cost-benefit
ratio of introducing laboratory-based screening into a compre-
hensive public health program for the control of syphilis,
gonorrhea, and chlamydia in populations at risk for HIV and
STIs in Latin America.
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Table 4. Diagnostic Performance of STI Symptoms; Lima, Trujillo, Chiclayo, Peru 2003–05.
STI Symptom Population
STI
Prevalence
Diagnostic
Sensitivity
Diagnostic
Specificity PPV NPV
Gonorrhea and/or
Chlamydia
Dysuria and/or
Discharge
Homosexual-identified Men 1.5% 50.0% 82.1% 4.0% 99.1%
Heterosexual-identified Men 5.6% 39.4% 72.4% 7.9% 95.2%
Women 16.2% 48.1% 44.4% 14.4% 81.5%
All 6.0% 42.1% 71.7% 8.6% 95.1%
Syphilis (RPR $1:8) Genital Ulcer Homosexual-identified Men 10.5% 3.5% 95.5% 8.3% 89.5%
Heterosexual-identified Men 1.4% 12.1% 92.0% 2.0% 98.7%
Women 2.2% 0.0% 93.6% 0.0% 97.7%
All 3.0% 6.2% 92.7% 2.5% 97.0%
Herpes Simplex
Virus Type 2
Genital Ulcer Homosexual-identified Men 69.0% 5.1% 96.7% 79.2% 29.5%
Heterosexual-identified Men 13.0% 14.3% 93.2% 24.7% 87.4%
Women 40.6% 7.7% 94.5% 50.0% 58.9%
All 24.9% 9.0% 93.5% 32.7% 74.7%
doi:10.1371/journal.pone.0007201.t004
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